OTIS three-lens brief
Evidence-based stock research on OTIS. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 12.9pp over 30 days. · Trading at 10% of its 52-week range — deep in the lower band.
- Trading at 10% of its 52-week range — deep in the lower band.
- Underperforming SPY by 12.9pp over 30 days.
- Analyst mean target $97.50 — 25% above current (14 analysts).
OTIS closed at $77.95 (-1.94%) as of 2026-04-25. Market cap: $29.91B. P/E (trailing) 20.7. Positives: analyst mean target $97.50 — 25% above current (14 analysts).. Concerns: trading at 10% of its 52-week range — deep in the lower band.; underperforming SPY by 12.9pp over 30 days.. Last quarter: Revenue $3.57B, net income $340.00M, free cash flow $1.80B.
Why three lenses on OTIS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine OTISacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/OTIS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath OTIS brief"></iframe>